longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Amgen

AMGN

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfileWeekly ReviewWeekly Review
LongbridgeAI

Current ValuationThe current P/E ratio is 25.18, within the reasonable range, cheaper than 33.31% of the time in the past 5 years, and the industry ranks 43/602, the industry Median -2.12.

25.18xP/E
$407.27Stock price
$16.17Earnings per share
25.18xP/E
Stock price$407.27Earnings per share$16.17

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
23.42x
Typical range
19.87x–28.02x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
019385776

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
AMGNUSAmgen
25.18x11.27%$220.18B
VRTXUSVertex Pharma
29.16x36.48%$128.44B
REGNUSRegeneron Pharma
17.48x5.79%$75.65B
UTHRUSUnited Therap
18.69x6.39%$24.51B
GMABUSGenmab A/S
26.96x24.38%$21.24B
ASNDUSAscendis Pharmac
17.37x473.98%$14.95B
EXELUSExelixis
16.68x16.46%$14.36B
NBIXUSNeurocrine Biosciences
20.27x50.69%$14.30B
HALOUSHalozyme Therap
29.35x181.51%$12.14B
TGTXUSTG Therap
18.59x64.86%$8.21B
PBYIUSPuma BioTech
19.01x37.70%$507.94M
KMDAUSKamada
21.27x36.43%$473.22M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.